We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Gastroenterology

Prehabilitation in Sarcopenic Patients Undergoing Major Hepatectomy: Evidence from the PREHEP Trial

MedXY Editorial Team•Oct 10, 2025•Gastroenterology
exercise therapyMajor HepatectomyNutritional SupportPostoperative MorbidityPrehabilitationSarcopenia

Highlight

  • Prehabilitation combining structured physical exercise and nutritional supplementation significantly reduces 90-day postoperative morbidity after major hepatectomy in sarcopenic patients.
  • The PREHEP randomized clinical trial demonstrated an absolute risk reduction of 36.7% in overall complications and eliminated major complications in the prehabilitation group.
  • Muscle mass and strength improved significantly only in patients receiving the multimodal prehabilitation program, underscoring the importance of targeted interventions for sarcopenia.

Study Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Neighborhood Disadvantage and Mortality Risk After Major Hepatectomy: Insights from the Area Deprivation IndexThis study links higher neighborhood deprivation with increased 90-day mortality following major hepatectomy, highlighting social determinants as vital preoperative risk factors.Aug 31, 2026Rapid Skeletal Muscle Loss in Cirrhosis: Predictors, Outcomes, and Implications for Clinical ManagementRapid skeletal muscle loss occurs in a significant subset of cirrhosis patients and independently predicts waitlist mortality, highlighting sarcopenia as a critical therapeutic target in liver disease management.Aug 4, 2026Nationwide Multimodal Prehabilitation Significantly Reduces Complications After Colorectal Cancer SurgeryA nationwide cohort study demonstrated that implementing a comprehensive multimodal prehabilitation program in colorectal cancer surgery patients lowers postoperative complications and shortens hospital stay across age and health status groJul 13, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Impact of Modified Frailty Index on Liver Transplant Outcomes: Insights from a Multicenter Cohort Study
This study demonstrates that the 5-variable Modified Frailty Index effectively predicts short- and long-term morbidity and mortality after liver transplantation, supporting its use in pretransplant assessment and perioperative planning.
Jul 8, 2026
Can Prehabilitation Reduce Complications After Spinal Fusion in Older Adults? What a New Randomized Trial SuggestsA multicenter randomized trial found that 4-week multimodal prehabilitation added to ERAS reduced 90-day complications after spinal fusion in adults aged 75 years or older.Jun 19, 2026
Prehabilitation During Neoadjuvant Chemotherapy May Improve Surgery Eligibility and Chemotherapy Delivery in Advanced Ovarian CancerA matched-cohort study found that multimodal prehabilitation during neoadjuvant chemotherapy improved chemotherapy delivery and increased the chance of interval debulking surgery in advanced ovarian cancer, with the strongest benefits seenAug 18, 2026